Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Biosimilars and FDA Talk at 4th Protein Therapeutics Conference October 19-21 - Carol A. Pratt, Ph.D. and Janet M. McNicholas, Ph.D. of K&L Gates to give a featured presentation entitled “Biosimilars: Coordinating FDA and Patent Strategies” at GTC’s 4th Protein Discovery & Therapeutics Conference on Oct 19-21 in San Diego
Biosimilars and FDA Talk at 4th Protein Therapeutics Conference October 19-21

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2011/08/25 - Carol A. Pratt, Ph.D. and Janet M. McNicholas, Ph.D. of K&L Gates to give a featured presentation entitled “Biosimilars: Coordinating FDA and Patent Strategies” at GTC’s 4th Protein Discovery & Therapeutics Conference on Oct 19-21 in San Diego.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr’s Pratt and McNicholas will discuss strategies for patenting biosimilars in conjunction with FDA regulations and how to overcome the challenges of FDA approval.

Dr. Pratt provides strategic advice regarding FDA requirements to manufacturers, distributors, importers and exporters of a wide range of medical and health products, including medical devices, drugs, dietary supplements, nutraceuticals, biologics and cosmetics. In her FDA practice, she advises clients on requirements for marketing clearance or approval, registration and listing, labeling and advertising, imports and exports, Good Clinical Practice, Good Laboratory Practice, and use of investigational drugs and devices.

Dr. McNicholas advises clients in the development and commercialization of worldwide patent portfolios. She writes and prosecutes patent applications for a broad range of life science technologies. Her practice includes conducting patentability and freedom-to-operate assessments, evaluating intellectual property, and mining both developing and mature patent portfolios for additional patenting opportunities to maximize value.

Other topics to be discussed at the conference include bi-specific and multi-specific fusion proteins, modified proteins, antibody drug conjugates, patenting strategies, non-IG scaffolds, antibody fragments, new peptide approaches, nutraceuticals, advances in expression systems, immunogenicity, aggregation, subvisible particles, stability and delivery of proteins.

Also presenting at the 4th Protein Discovery & Therapeutics Conference are organizations active in the field including Affibody, Affimed, Albany Medical College, Ambrx, Anaptysbio, Centyrex, ImmunGene, Johnson & Johnson, MacroGenics, MedImmune, Merus, Micromet AG, NCI, NIH, Nektar Therapeutics, Novartis, NovImmune SA, Pfizer, Profectus BioSciences, RC Technologies, Roche, Scripps Research Institute, Zyngenia and other experts in protein therapeutics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Biosimilars and FDA Talk at 4th Protein Therapeutics Conference October 19-21

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  BizJobs.com

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today